Silvia Rosellini

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

Christophe Massard, Stefan Michiels, Charles Ferté et al. · Cancer Discovery · 2017 · 747 citations

Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial

Cécile Jovelet, Ecaterina Ileana, Marie‐Cécile Le Deley et al. · Clinical Cancer Research · 2016 · 111 citations · Full text

Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status

Dan Ou, Pierre Blanchard, Silvia Rosellini et al. · Oral Oncology · 2017 · 98 citations · Full text

Adaptive Radiotherapy, Advanced Head, Radiomics Signature +10

Outcomes of multimodal management for sinonasal squamous cell carcinoma

Arnaud Paré, Pierre Blanchard, Silvia Rosellini et al. · Journal of Cranio-Maxillofacial Surgery · 2017 · 57 citations

Surgical Oncology, Medicine, Cancer Management +6

Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01)

Vania Tacher, Marie‐Cécile Le Deley, Antoine Hollebecque et al. · European Journal of Cancer · 2016 · 45 citations

Medical Imaging, Medicine, Image-guided Tumour Biopsies +10